Collaboration on GPCRs and Ion Channel Technology

A drug discovery agreement to collaborate on G protein-coupled receptors (GPCRs) and ion channel technologies has been announced by Bionomics (Adelaide, Australia) and PerkinElmer, Inc. (Boston, MA, USA).

The collaboration recognizes the value of Bionomics' ionX program for the discovery and development of ion channel drugs for central nervous system (CNS) disorders, specifically epilepsy and anxiety. Under the agreement, the two companies will collaborate on the evaluation and optimization of new ion channel reagents.

Bionomics will incorporate the Image Trak, PerkinElmer's kinetic cellular screening platform, into Bionomics' CNS drug discovery program. In addition, Bionomics will serve as a reference site for PerkinElmer's cellular screening platforms in the Asian market. Image Trak is a cellular imaging platform that utilizes patented fiberoptic imaging and fully integrated liquid handling, making it well suited for automated high-throughput screening against ion channels and GPCRs, using both standard and highly sensitive ratiometric probes.

"We look forward to further building our relationship with Bionomics and enabling them to develop the best fluorescent screening technologies available for ion channel targeted drug discovery,” said Peter Coggins, president, PerkinElmer Life and Analytical Sciences.




Related Links:
Bionomics
PerkinElmer